FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414225546> ?p ?o ?g. }

• W2414225546 endingPage "11954" @default.
• W2414225546 startingPage "11944" @default.
• W2414225546 abstract "Two major subtypes of melanoma include cutaneous melanoma and mucosal melanoma. The latter type is rare and usually occurs in the head and neck region. High-dose interferon-α-2b (IFN-α-2b) has proven effective in the treatment of cutaneous melanoma. Recently, a regimen of temozolomide plus cisplatin was reported more likely to improve relapse-free survival and overall survival than high-dose IFN-α-2b for mucosal melanoma. We conducted this study to analyze the therapeutic effect of high-dose IFN-α-2b for patients with oral mucosal melanoma who had received prior chemotherapy. One hundred and seventeen patients with stage III-IVa oral mucosal melanoma who had received chemotherapy were analyzed. The overall survival and relapse-free survival were compared between the patients with/without high-dose IFN-α-2b. The results indicate that the IFN-α-2b treatment group had a longer relapse-free survival rate (P = 0.0169) as compared to the control group. However, the overall survival was not significant between the two groups (P = 0.096), except in patients in stage IVa, whose overall survival increased by 20 months (P = 0.0146). The adverse reactions included a drug-induced influenza-like syndrome, gastrointestinal responses, myelosuppression, and hepatoxicity, which were predominantly of grade 1-2 and reversible. Thus, patients with resected oral mucosal melanoma, even those who have received chemotherapy, could benefit from the treatment of high-dose IFN-α-2b." @default.
• W2414225546 created "2016-06-24" @default.
• W2414225546 creator A5018598306 @default.
• W2414225546 creator A5028430065 @default.
• W2414225546 creator A5028877051 @default.
• W2414225546 creator A5033199090 @default.
• W2414225546 creator A5033509221 @default.
• W2414225546 creator A5061005277 @default.
• W2414225546 creator A5061488645 @default.
• W2414225546 creator A5063145199 @default.
• W2414225546 creator A5068073856 @default.
• W2414225546 creator A5089804222 @default.
• W2414225546 date "2015-01-01" @default.
• W2414225546 modified "2023-10-02" @default.
• W2414225546 title "Interferon-α-2b as an adjuvant therapy prolongs survival of patients with previously resected oral muscosal melanoma" @default.
• W2414225546 cites W1545177819 @default.
• W2414225546 cites W1828940258 @default.
• W2414225546 cites W1971542900 @default.
• W2414225546 cites W1989121777 @default.
• W2414225546 cites W2033087055 @default.
• W2414225546 cites W2082841886 @default.
• W2414225546 cites W2097691839 @default.
• W2414225546 cites W2112766682 @default.
• W2414225546 cites W2117903190 @default.
• W2414225546 cites W2123903509 @default.
• W2414225546 cites W2132757216 @default.
• W2414225546 cites W2137978694 @default.
• W2414225546 cites W2150977156 @default.
• W2414225546 cites W2156266404 @default.
• W2414225546 cites W2162502360 @default.
• W2414225546 cites W2172512811 @default.
• W2414225546 cites W2473618963 @default.
• W2414225546 doi "https://doi.org/10.4238/2015.october.5.8" @default.
• W2414225546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26505342" @default.
• W2414225546 hasPublicationYear "2015" @default.
• W2414225546 type Work @default.
• W2414225546 sameAs 2414225546 @default.
• W2414225546 citedByCount "12" @default.
• W2414225546 countsByYear W24142255462016 @default.
• W2414225546 countsByYear W24142255462017 @default.
• W2414225546 countsByYear W24142255462018 @default.
• W2414225546 countsByYear W24142255462019 @default.
• W2414225546 countsByYear W24142255462021 @default.
• W2414225546 countsByYear W24142255462022 @default.
• W2414225546 crossrefType "journal-article" @default.
• W2414225546 hasAuthorship W2414225546A5018598306 @default.
• W2414225546 hasAuthorship W2414225546A5028430065 @default.
• W2414225546 hasAuthorship W2414225546A5028877051 @default.
• W2414225546 hasAuthorship W2414225546A5033199090 @default.
• W2414225546 hasAuthorship W2414225546A5033509221 @default.
• W2414225546 hasAuthorship W2414225546A5061005277 @default.
• W2414225546 hasAuthorship W2414225546A5061488645 @default.
• W2414225546 hasAuthorship W2414225546A5063145199 @default.
• W2414225546 hasAuthorship W2414225546A5068073856 @default.
• W2414225546 hasAuthorship W2414225546A5089804222 @default.
• W2414225546 hasBestOaLocation W24142255461 @default.
• W2414225546 hasConcept C121608353 @default.
• W2414225546 hasConcept C126322002 @default.
• W2414225546 hasConcept C143998085 @default.
• W2414225546 hasConcept C197934379 @default.
• W2414225546 hasConcept C203014093 @default.
• W2414225546 hasConcept C2776178377 @default.
• W2414225546 hasConcept C2776283816 @default.
• W2414225546 hasConcept C2776694085 @default.
• W2414225546 hasConcept C2777389519 @default.
• W2414225546 hasConcept C2777658100 @default.
• W2414225546 hasConcept C2777701055 @default.
• W2414225546 hasConcept C2777863537 @default.
• W2414225546 hasConcept C2780964509 @default.
• W2414225546 hasConcept C2781186586 @default.
• W2414225546 hasConcept C2781228144 @default.
• W2414225546 hasConcept C2781413609 @default.
• W2414225546 hasConcept C2909179924 @default.
• W2414225546 hasConcept C502942594 @default.
• W2414225546 hasConcept C71924100 @default.
• W2414225546 hasConcept C90924648 @default.
• W2414225546 hasConceptScore W2414225546C121608353 @default.
• W2414225546 hasConceptScore W2414225546C126322002 @default.
• W2414225546 hasConceptScore W2414225546C143998085 @default.
• W2414225546 hasConceptScore W2414225546C197934379 @default.
• W2414225546 hasConceptScore W2414225546C203014093 @default.
• W2414225546 hasConceptScore W2414225546C2776178377 @default.
• W2414225546 hasConceptScore W2414225546C2776283816 @default.
• W2414225546 hasConceptScore W2414225546C2776694085 @default.
• W2414225546 hasConceptScore W2414225546C2777389519 @default.
• W2414225546 hasConceptScore W2414225546C2777658100 @default.
• W2414225546 hasConceptScore W2414225546C2777701055 @default.
• W2414225546 hasConceptScore W2414225546C2777863537 @default.
• W2414225546 hasConceptScore W2414225546C2780964509 @default.
• W2414225546 hasConceptScore W2414225546C2781186586 @default.
• W2414225546 hasConceptScore W2414225546C2781228144 @default.
• W2414225546 hasConceptScore W2414225546C2781413609 @default.
• W2414225546 hasConceptScore W2414225546C2909179924 @default.
• W2414225546 hasConceptScore W2414225546C502942594 @default.
• W2414225546 hasConceptScore W2414225546C71924100 @default.
• W2414225546 hasConceptScore W2414225546C90924648 @default.
• W2414225546 hasIssue "4" @default.
• W2414225546 hasLocation W24142255461 @default.

• next